Showing 3 Result(s)

Neuralink’s First Human Trial Patient

In the annals of scientific history, Noland Arbaugh’s name will forever be etched as the first-ever human trial patient—a trailblazer who dared to defy the limits of possibility and embrace the unknown. As Neuralink continues to push the boundaries of what is achievable, Arbaugh’s story will serve as a reminder of the boundless potential that lies within the human spirit.

Forever Chemicals Pose Heart Risks, Scientists Warn

The revelation of PFAS’ harmful effects on heart health represents a significant milestone in our understanding of the risks posed by these ubiquitous chemicals. As scientists sound the alarm over the cardiovascular toxicity of forever chemicals, concerted efforts are needed to mitigate the pervasive threat they pose to public health and the environment.